Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
2014 GECCO Investigator Meeting
It is recognized that genetic variants play an important role in conferring risk of colorectal cancer. To comprehensively study the millions of genetic variations across the genome, large scale studies are becoming increasingly important for elucidating inherited risk factors and their interaction with environmental factors.
The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort of researchers from North America, Australia, and Europe, using data from over 40,000 participants. The coordinating center for this international consortium is based at the Fred Hutchinson Cancer Research Center (Principal investigator: Ulrike Peters; lead statistician: Li Hsu).
GECCO aims to accelerate the discovery of colorectal cancer-related variants by replicating and characterizing Genome Wide Association Study (GWAS) findings, conducting a large-scale meta-analysis of existing and newly generated GWAS data, and investigating how genetic variants are modified by environmental risk factors. We are able to study the impact of common and rare genetic variants across the entire genome by performing whole genome sequencing and genotyping. Additionally, a crucial part of this work is the ongoing harmonization of detailed clinical, epidemiologic, and outcome data across the studies in the consortium.
The large amount of data that GECCO has collected for CRC allows for investigation into survival and risk modeling as well. GECCO is now aiming to broaden its investigation of colorectal cancer risk by examining tumor characteristics in concert with host characteristics.
Studies working with GECCO
French Association Study Evaluating RISK for sporadic colorectal cancer (ASTERISK)
Cancer Prevention Study II (CPSII)
A case-control study from the University of Hawai’i (Colo 2&3)
Colorectal Cancer Study of Austria (CORSA)
Darmkrebs: Chancen der Verhütung durch Screening (DACHS)
Diet, Activity, and Lifestyle Study (DALS)
European Prospective Investigation into Cancer (EPIC)
Health Professionals Follow-up Study (HPFS)
Multiethnic Cohort (MEC)
Molecular Epidemiology of Colorectal Cancer (MECC) study
North German Case Control Study (NGCCS)
Nurses' Health Study (NHS)
Ontario Colorectal Cancer Family Registry (OFCCR)
Physicians' Health Study (PHS)
Prostate, Lung, Colorectal, and Ovarian (PLCO)
Post-Menopausal Hormone-CCFR Study (PMH-CCFR)
CancerScreening Trial; VITamins And Lifestyle (VITAL) cohort
Women's Health Initiative (WHI)
Additionally, the Colon Cancer Family Registry (CCFR) is collaborating with GECCO on many analyses.
For questions or additional information please contact:
Ulrike (Riki) Peters, PhD, MPH
Member Fred Hutchinson Cancer Research Center
Research Professor University of Washington
PO Box 19024
1100 Fairview Avenue N, M4-B402
Seattle, WA 98109-1024
Phone: (206) 667-2450
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.